Del kratom a la mitraginina y sus derivados: efectos fisiológicos y conductuales relacionados con el uso, el abuso y la adicción

Publicaciones

Del kratom a la mitraginina y sus derivados: efectos fisiológicos y conductuales relacionados con el uso, el abuso y la adicción

30 septiembre 2013

El kratom se usa generalmente para mejorar la tolerancia frente al trabajo duro o como un sustituto en el autotratamiento de la dependencia de opiáceos.

Más información, en inglés, está disponible abajo.

Suscríbase a las Alertas mensuales del IDPC para recibir información sobre cuestiones relacionadas con políticas sobre drogas.

Kratom (or Ketum) is a psychoactive plant preparation used in Southeast Asia. It is derived from the plant Mitragyna speciosa Korth. Kratom as well as its main alkaloid, mitragynine, currently spreads around the world. Thus, addiction potential and adverse health consequences are becoming an important issue for health authorities. Here we reviewed the available evidence and identified future research needs. It was found that mitragynine and M. speciosa preparations are systematically consumed with rather well defined instrumentalization goals, e.g. to enhance tolerance for hard work or as a substitute in the self-treatment of opiate addiction.

There is also evidence from experimental animal models supporting analgesic, muscle relaxant, anti-inflammatory as well as strong anorectic effects. In humans, regular consumption may escalate, lead to tolerance and may yield aversive withdrawal effects. Mitragynine and its derivatives actions in the central nervous system involve μ-opioid receptors, neuronal Ca2+ channels and descending monoaminergic projections. Altogether, available data currently suggest both, a therapeutic as well as an abuse potential.

Click here to read the full publication (Restricted access)

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.